| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| MS | Morgan Stanley | $47.68 | $83.19B | N/A |
Malaysia bars entry of MS Westerdam cruise passengers after American tests positive for virus
https://www.cnbc.com/2020/02/17/coronavirus-malaysia-bars-entry-of-ms-westerdam-cruise-passengers.html
Feb 17, 2020 - The 83-year-old American woman arrived in Malaysia after leaving the MS Westerdam cruise ship that docked in Cambodia last week.
0
BofA (BAC) CEO Moynihan's 2019 Compensation Remains Stable
http://www.zacks.com/stock/news/758291/bofa-bac-ceo-moynihans-2019-compensation-remains-stable?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-758291
Feb 10, 2020 - Bank of America's (BAC) chief executive officer Brian T. Moynihan's total compensation package for 2019 remains unrevised at the 2018 level of $26.5 million.
0
Has Morgan Stanley (MS) Outpaced Other Finance Stocks This Year?
http://www.zacks.com/stock/news/754569/has-morgan-stanley-ms-outpaced-other-finance-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-754569
Feb 07, 2020 - Is (MS) Outperforming Other Finance Stocks This Year?
0
Murder of MS-13 gang witness NOT because of reform laws after all: Nassau cops
http://www.nydailynews.com/new-york/ny-nassau-witness-murder-20200206-cv4i6cfbsbak7pvvbztxe3xd5y-story.html
Feb 06, 2020 -
The killing of a witness in an MS-13 gang trial was not the result of criminal justice reforms after all, Nassau County cops said Thursday.
In the days after Wilmer Maldonado Rodriguez’s Sunday slaying, Nassau County Police Commissioner Patrick Ryder said the man was targeted because a protective...
0
Sanofi BTK inhibitor successful in mid-stage MS study; shares up 3% premarket
https://seekingalpha.com/news/3539068-sanofi-btk-inhibitor-successful-in-mid-stage-ms-study-shares-up-3-premarket?utm_source=feed_news_all&utm_medium=referral
Feb 06, 2020 - Sanofi (NASDAQ:SNY) perks up 3% premarket on light volume in reaction to positive results from a Phase 2b clinical trial evaluating SAR442168 in patients with relapsing multiple sclerosis (MS)
0
Biogen Soars on Patent Win for MS Drug Tecfidera Over Mylan
http://www.zacks.com/stock/news/752713/biogen-soars-on-patent-win-for-ms-drug-tecfidera-over-mylan?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-752713
Feb 06, 2020 - The U.S. Patent and Trademark Office imparts a ruling in favor of Biogen (BIIB) over generic drugmaker Mylan to protect the patent of its best-selling multiple sclerosis drug, Tecfidera.
0
Zacks.com featured highlights include: Denny's, Garmin, LPL Financial and Morgan Stanley
http://www.zacks.com/stock/news/746580/zackscom-featured-highlights-include-dennys-garmin-lpl-financial-and-morgan-stanley?cid=CS-ZC-FT-press_releases-746580
Feb 03, 2020 - Zacks.com featured highlights include: Denny's, Garmin, LPL Financial and Morgan Stanley
0
Top Ranked Momentum Stocks to Buy for January 31st
http://www.zacks.com/commentary/742436/top-ranked-momentum-stocks-to-buy-for-january-31st?cid=CS-ZC-FT-zacks_#1_rank_additions-742436
Jan 31, 2020 - Top Ranked Momentum Stocks to Buy for January 31st
0
Earnings Season Scorecard and Research Reports for Apple, PetroChina & Others
http://www.zacks.com/research-daily/740844/earnings-season-scorecard-and-research-reports-for-apple-petrochina-others?cid=CS-ZC-FT-research_daily-740844
Jan 30, 2020 - Earnings Season Scorecard and Research Reports for Apple, PetroChina & Others
0
Evercore (EVR) Stock Gains 10% as Q4 Earnings Beat Estimates
http://www.zacks.com/stock/news/740289/evercore-evr-stock-gains-10-as-q4-earnings-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-740289
Jan 30, 2020 - While fall in expenses and rise in assets under management balance support Evercore's (EVR) Q4 results, decline in net revenues hurts to some extent.
0